SecBot SecBot
8-K ·Filed Apr 10, 2026

XCUR

EXICURE, INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC0001698530-26-000036
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Traders should monitor whether the new leadership brings improved financial discipline or operational advancements, particularly in governance and cross-border operations, though immediate financial impact is minimal.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
XCUR ▼ -55.82% at T+60d
NEUTRAL call -55.82% · α vs SPY -64.74% · entry $3.85 → $1.70
Entry = T+0 close
Apr 10, 2026
via day close
T+1d
-1.56%
call -1.56% · α -2.77%
$3.79
settled 7mo ago
T+5d
-2.08%
call -2.08% · α -5.37%
$3.77
settled 6mo ago
T+20d
-12.16%
call -12.16% · α -19.89%
$3.38
settled 6mo ago
T+60d
-55.82%
call -55.82% · α -64.74%
$1.70
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Exicure, Inc. appointed Yoontae Han as a new director and Chair of the Audit Committee, and Young Seung Ko as Chief Operating Officer. These additions aim to strengthen governance and operational leadership in the pharmaceutical company.

Key Facts

  • Yoontae Han was appointed to the Board of Directors and Audit Committee on April 8, 2026, with an annual retainer of $20,000.
  • Dongho Lee was appointed Chair of the Audit Committee.
  • Young Seung Ko was appointed Chief Operating Officer on April 9, 2026, bringing over 20 years of experience in enterprise software and public company operations.
  • The company will pay an additional $10,000 monthly to Innocircle Advisors Inc. for COO services under an amended executive services agreement.

Financial Impact

Annual board compensation of $20,000 for Han; $120,000 annual cost for Ko's COO role via advisory firm.

operating expenses

Risk Factors

  • Integration risk with new leadership in a small-cap biopharma firm.
  • Potential for increased advisory costs if reliance on third-party executives expands.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001698530-26-000036
Document: 0001698530-26-000036-index-headers.html0001698530-26-000036
Document: 0001698530-26-000036-index.html0001698530-26-000036
Document: 0001698530-26-000036.txt0001698530-26-000036
6 reports for XCUR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for XCUR — sortable, filterable
TypeNow
Sep 16, 2026
5w ago
8-K
BEARISH ★ 7/10
$1.33 $1.15▲ +13.53%▲ +16.71%$1.07 (+19.55%)
Jun 30, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$2.08 $1.75▼ −15.87%▼ −14.84%$1.07 (−48.56%)
Jun 1, 2026
21w ago
Press Release
NEUTRAL ★ 4/10
$3.11 $1.98▼ −36.33%▼ −34.77%$1.07 (−65.59%)
Jun 1, 2026
21w ago
8-K
NEUTRAL ★ 3/10
$3.33 $2.08▼ −37.54%▼ −36.24%$1.07 (−67.87%)
Apr 10, 2026
28w ago
8-K
NEUTRAL ★ 3/10
$3.85 $3.38▼ −12.16%▼ −19.89%$1.07 (−72.19%)
Mar 25, 2026
30w ago
Press Release
BEARISH ★ 8/10
$4.61 $3.47▲ +24.73%▲ +35.39%$1.07 (+76.79%)
Showing 6 of 6

US Market Status

Market Open — Closes in 4h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 10, 2026